1
|
Lisanti MP, Sargiacomo M, Graeve L,
Saltiel AR and Rodriguez-Boulan E: Polarized apical distribution of
glycosyl-phosphatidylinositol-anchored proteins in a renal
epithelial cell line. Proc Natl Acad Sci USA. 85:pp. 9557–9561.
1988; View Article : Google Scholar : PubMed/NCBI
|
2
|
Fujita M and Kinoshita T: GPI-anchor
remodeling: Potential functions of GPI-anchors in intracellular
trafficking and membrane dynamics. Biochim Biophys Acta.
1821:1050–1058. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Davis LS, Patel SS, Atkinson JP and Lipsky
PE: Decay-accelerating factor functions as a signal transducing
molecule for human T cells. J Immunol. 141:2246–2252.
1988.PubMed/NCBI
|
4
|
Thompson LF, Ruedi JM, Glass A, Low MG and
Lucas AH: Antibodies to 5′-nucleotidase (CD73), a
glycosyl-phosphatidylinositol-anchored protein, cause human
peripheral blood T cells to proliferate. J Immunol. 143:1815–1821.
1989.PubMed/NCBI
|
5
|
Presky DH, Low MG and Shevach EM: Role of
phosphatidylinositol-anchored proteins in T cell activation. J
Immunol. 144:860–868. 1990.PubMed/NCBI
|
6
|
Korty PE, Brando C and Shevach EM: CD59
functions as a signal-transducing molecule for human T cell
activation. J Immunol. 146:4092–4098. 1991.PubMed/NCBI
|
7
|
Corda D, Zizza P, Varone A, Bruzik KS and
Mariggiò S: The glycerophosphoinositols and their cellular
functions. Biochem Soc Trans. 40:101–107. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Davies A, Simmons DL, Hale G, Harrison RA,
Tighe H, Lachmann PJ and Waldmann H: CD59, an LY-6-like protein
expressed in human lymphoid cells, regulates the action of the
complement membrane attack complex on homologous cells. J Exp Med.
170:637–654. 1989. View Article : Google Scholar : PubMed/NCBI
|
9
|
Farkas I, Baranyi L, Ishikawa Y, Okada N,
Bohata C, Budai D, Fukuda A, Imai M and Okada H: CD59 blocks not
only the insertion of C9 into MAC but inhibits ion channel
formation by homologous C5b-8 as well as C5b-9. J Physiol.
539:537–545. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Meri S, Morqan BP, Davies A, Daniels RH,
Olavesen MG, Waldmann H and Lachmann PJ: Human protectin (CD59), an
18,000–20,000 MW complement lysis restricting factor, inhibits
C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology.
71:1–9. 1990.PubMed/NCBI
|
11
|
Rollins SA and Sims PJ: The
complement-inhibitory activity of CD59 resides in its capacity to
block incorporation of C9 into membrane C5b-9. J Immunol.
144:3478–3483. 1990.PubMed/NCBI
|
12
|
Hideshima T, Okada N and Okada H:
Expression of HEF20, a regulatory molecule of complement
activation, on peripheral blood mononuclear cells. Immunology.
69:396–401. 1990.PubMed/NCBI
|
13
|
Meri S, Waldmann H and Lachmann PJ:
Distribution of protectin (CD59), a complement membrane attack
inhibitor, in normal human tissues. Lab Invest. 65:532–537.
1991.PubMed/NCBI
|
14
|
Kimberley FC, Sivasankar B and Paul Morgan
B: Alternative roles for CD59. Mol Immunol. 44:73–81. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang W, Sloan-Lancaster J, Kitchen J,
Trible RP and Samelson LE: LAT: The ZAP-70 tyrosine kinase
substrate that links T cell receptor to cellular activation. Cell.
92:83–92. 1998. View Article : Google Scholar : PubMed/NCBI
|
16
|
Su YW and Jumaa H: LAT links the pre-BCR
to calcium signaling. Immunity. 19:295–305. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Facchetti F, Chan JK, Zhang W, Tironi A,
Chilosi M, Parolini S, Notarangelo LD and Samelson LE: Linker for
activation of T cells (LAT), a novel immunohistochemical marker for
T cells, NK cells, mast, cells and megakaryocytes: Evaluation in
normal and pathological conditions. Am J Pathol. 154:1037–1046.
1999. View Article : Google Scholar : PubMed/NCBI
|
18
|
Weber JR, Orstavik S, Torqersen KM,
Danbolt NC, Berg SF, Ryan JC, Taskén K, Imboden JB and Vaage JT:
Molecular cloning of the cDNA encoding pp36, a
tyrosine-phosphorylated adaptor protein selectively expressed by T
cells and natural killer cells. J Exp Med. 187:1157–1161. 1998.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Li CY, Peng J, Ren LP, Gan LX, Lu XJ, Liu
Q, Gu W and Guo XJ: Roles of histone hypoacetylation in LAT
expression on T cells and Th2 polarization in allergic asthma. J
Transl Med. 11:262013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang W, Trible RP and Samelson LE: LAT
palmitoylation: Its essential role in membrane microdomain
targeting and tyrosine phosphorylation during T cell activation.
Immunity. 9:239–246. 1998. View Article : Google Scholar : PubMed/NCBI
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Dustin ML and Depoil D: New insights into
the T cell synapse from single molecule techniques. Nat Rev
Immunol. 11:672–684. 2011. View
Article : Google Scholar : PubMed/NCBI
|
23
|
Wange RL: LAT, the linker for activation
of T cells: a bridge between T cell-specific and general signaling
pathways. Sci STKE. 2000:re12000.PubMed/NCBI
|
24
|
Chen Y, Thelin WR, Yang B, Milgram SL and
Jacobson K: Transient anchorage of cross-linked
glycosyl-phosphatidylinositol-anchored proteins depends on
cholesterol, Src family kinases, caveolin and phosphoinositides. J
Cell Biol. 175:169–178. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Okada H, Nagami Y, Takahashi K, Okada N,
Hideshima T, Takizawa H and Kondo J: 20 KDa homologous restriction
factor of complement resembles T cell activating protein. Biochem
Biophys Res Commun. 162:1553–1559. 1989. View Article : Google Scholar : PubMed/NCBI
|
26
|
Lipp AM, Juhasz K, Paar C, Ogris C,
Eckerstorfer P, Thuenauer R, Hesse J, Nimmervoll B, Stockinger H,
Schütz GJ, et al: Lck mediates signal transmission from CD59 to the
TCR/CD3 pathway in Jurkat T cells. PLoS One. 9:e859342014.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Suzuki KG: Single-Molecule Imaging of
Signal Transduction via GPI-Anchored Receptors. Methods Mol Biol.
1376:229–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Stefanová I, Horejsí V, Ansotegui IJ,
Knapp W and Stockinger H: GPI-anchored cell-surface molecules
complexed to protein tyrosine kinases. Science. 254:1016–1019.
1991. View Article : Google Scholar : PubMed/NCBI
|
29
|
Simons K and Ikonen E: Functional rafts in
cell membranes. Nature. 387:569–572. 1997. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jacobson K, Mouritsen OG and Anderson RG:
Lipid rafts: At a crossroad between cell biology and physics. Nat
Cell Biol. 9:7–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Goswami D, Gowrishankar K, Bilgrami S,
Ghosh S, Raghupathy R, Chadda R, Vishwakarma R, Rao M and Mayor S:
Nanoclusters of GPI-anchored proteins are formed by cortical
actin-driven activity. Cell. 135:1085–1097. 2008. View Article : Google Scholar : PubMed/NCBI
|
32
|
Lee MY, Ryu JM, Lee SH, Park JH and Han
HJ: Lipid rafts play an important role for maintenance of embryonic
stem cell self-renewal. J Lipid Res. 51:2082–2089. 2010. View Article : Google Scholar : PubMed/NCBI
|
33
|
Kabouridis PS, Magee AI and Ley SC:
S-acylation of LCK protein tyrosine kinase is essential for its
signaling function in T lymphocytes. EMBO J. 16:4983–4998. 1997.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Cinek T and Horejsí V: The nature of large
noncovalent complexes containing
glycosyl-phosphatidylinositol-anchored membrane glycoproteins and
protein tyrosine kinases. J Immunol. 149:2262–2270. 1992.PubMed/NCBI
|
35
|
Suzuki KG: Lipid rafts generate
digital-like signal transduction in cell plasma membranes.
Biotechnol J. 7:753–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Subczynski WK and Kusumi A: Dynamics of
raft molecules in the cell and artificial membranes: Approaches by
pulse EPR spin labeling and single molecule optical microscopy.
Biochim Biophys Acta. 1610:231–243. 2003. View Article : Google Scholar : PubMed/NCBI
|
37
|
Fuller DM and Zhang W: Regulation of
lymphocyte development and activation by the LAT family of adapter
proteins. Immunol Rev. 232:72–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Bartelt RR and Houtman JC: The adaptor
protein LAT serves as an integration node for signaling pathways
that drive T cell activation. Wiley Interdiscip Rev Syst Biol Med.
5:101–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
39
|
Balagopalan L, Coussens NP, Sherman E,
Samelson LE and Sommers CL: The LAT story: A tale of cooperativity,
coordination, and choreography. Cold Spring Harb Perspect Biol.
2:a0055122010. View Article : Google Scholar : PubMed/NCBI
|
40
|
Lin J, Weiss A and Finco TS: Localization
of LAT in glycolipid-enriched microdomains is required for T cell
activation. J Biol Chem. 274:28861–28864. 1999. View Article : Google Scholar : PubMed/NCBI
|
41
|
Jiang Y and Cheng H: Evidence of LAT as a
dual substrate for Lck and Syk in T lymphocytes. Leuk Res.
31:541–545. 2007. View Article : Google Scholar : PubMed/NCBI
|
42
|
Tanimura N, Saitoh S, Kawano S, Kosugi A
and Miyake K: Palmitoylation of LAT contributes to its subcellular
localization and stability. Biochem Biophys Res Commun.
341:1177–1183. 2006. View Article : Google Scholar : PubMed/NCBI
|
43
|
Ferguson MAJ, Kinoshita T and Hart GW:
Glycosylphosphatidylinositol anchorsEssentials of Glycobiology.
Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR,
Hart GW and Etzler ME: 2nd. Cold Spring Harbor; New York, NY: pp.
3–6. 2009
|
44
|
Deckert M, Ticchioni M, Mari B, Mary D and
Bernard A: The glycosylphosphatidylinositol-anchored CD59 protein
stimulates both T cell receptor zeta/ZAP-70-dependent and
-independent signaling pathways in T cells. Eur J Immunol.
25:1815–1822. 1995. View Article : Google Scholar : PubMed/NCBI
|
45
|
Li B, Chu X, Gao M and Xu Y: The effects
of CD59 gene as a target gene on breast cancer cells. Cell Immunol.
272:61–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
46
|
Weiss A and Littman DR: Signal
transduction by lymphocyte antigen receptors. Cell. 76:263–274.
1994. View Article : Google Scholar : PubMed/NCBI
|
47
|
Wange RL and Samelson LE: Complex
complexes: Signaling at the TCR. Immunity. 5:197–205. 1996.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Trüb T, Frantz JD, Miyazaki M, Band H and
Shoelson SE: The role of a lymphoid-restricted, Grb2-like
SH3-SH2-SH3 protein in T cell receptor signaling. J Biol Chem.
272:894–902. 1997. View Article : Google Scholar : PubMed/NCBI
|
49
|
Fukazawa T, Reedquist KA, Panchamoorthy G,
Soltoff S, Trub T, Druker B, Cantley L, Shoelson SE and Band H: T
cell activation-dependent association between the p85 subunit of
the phosphatidylinositol 3-kinase and Grb2/phospholipase C-gamma
1-binding phosphotyrosyl protein pp36/38. J Biol Chem.
270:20177–20182. 1995. View Article : Google Scholar : PubMed/NCBI
|
50
|
Sieh M, Batzer A, Schlessinger J and Weiss
A: GRB2 and phospholipase C-gamma 1 associate with a 36- to
38-kilodalton phosphotyrosine protein after T-cell receptor
stimulation. Mol Cell Biol. 14:4435–4442. 1994. View Article : Google Scholar : PubMed/NCBI
|
51
|
Kalland ME, Solheim SA, Skånland SS,
Taskén K and Berge T: Modulation of proximal signaling in normal
and transformed B cells by transmembrane adapter Cbp/PAG. Exp Cell
Res. 318:1611–1619. 2012. View Article : Google Scholar : PubMed/NCBI
|